Orgenesis Inc.
ORGS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1 | $36 | $36 | $8 |
| % Growth | -98.5% | 1.5% | 364% | – |
| Cost of Goods Sold | $6 | $20 | $28 | $31 |
| Gross Profit | -$6 | $16 | $7 | -$23 |
| % Margin | -1,080.2% | 43.3% | 20.7% | -306.4% |
| R&D Expenses | $11 | $6 | $37 | $84 |
| G&A Expenses | $35 | $16 | $15 | $19 |
| SG&A Expenses | $35 | $16 | $15 | $19 |
| Sales & Mktg Exp. | $0 | $0 | -$1 | -$0 |
| Other Operating Expenses | $2 | $1 | -$1 | $0 |
| Operating Expenses | $48 | $23 | $50 | $103 |
| Operating Income | -$54 | -$8 | -$17 | -$96 |
| % Margin | -10,120% | -20.9% | -47.3% | -1,251.7% |
| Other Income/Exp. Net | -$11 | -$4 | -$1 | -$1 |
| Pre-Tax Income | -$64 | -$12 | -$18 | -$97 |
| Tax Expense | $0 | $0 | $0 | -$2 |
| Net Income | -$55 | -$15 | -$18 | -$96 |
| % Margin | -10,445.5% | -41.3% | -50.9% | -1,252.1% |
| EPS | -1.91 | -0.59 | -0.74 | -4.46 |
| % Growth | -223.7% | 20.3% | 83.4% | – |
| EPS Diluted | -1.91 | -0.59 | -0.74 | -4.46 |
| Weighted Avg Shares Out | 29 | 25 | 24 | 21 |
| Weighted Avg Shares Out Dil | 29 | 25 | 24 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $0 | $0 |
| Interest Expense | $2 | $2 | $0 | $1 |
| Depreciation & Amortization | $2 | $2 | $2 | $1 |
| EBITDA | -$61 | -$8 | -$16 | -$94 |
| % Margin | -11,456.2% | -22.6% | -44.3% | -1,231.1% |